Fig. 5
From: Comprehensive analyses reveal the carcinogenic and immunological roles of ANLN in human cancers
Analysis of ANLN protein phosphorylation in cancers using CPTAC of UACLAN database. A Phosphorylation sites with significant differences are marked in ANLN protein (NP_061155.2, S6, S102, S182, S225, S272, S485, S518, S562, S664, S755, S792, S800 sites). B Expression of different ANLN protein phosphorylation sites in breast cancer. C Expression of ANLN protein phosphorylation sites S182 and S485 in LUAD, ovarian cancer and UCEC. D Expression of ANLN phosphorylation sites S225, S755, S792 and S518 in cancers